BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23322200)

  • 21. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas.
    Zhang Q; Liu JH; Liu JL; Qi CT; Yan L; Chen Y; Yu Q
    BMC Cancer; 2019 Nov; 19(1):1044. PubMed ID: 31690270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LINC00037 Inhibits Proliferation of Renal Cell Carcinoma Cells in an Epidermal Growth Factor Receptor-Dependent Way.
    Gong X; Du X; Xu Y; Zheng W
    Cell Physiol Biochem; 2018; 45(2):523-536. PubMed ID: 29393141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis.
    Nomura T; Huang WC; Zhau HE; Wu D; Xie Z; Mimata H; Zayzafoon M; Young AN; Marshall FF; Weitzmann MN; Chung LW
    Clin Cancer Res; 2006 Dec; 12(24):7294-305. PubMed ID: 17189401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.
    Zu Y; Liu L; Lee MY; Xu C; Liang Y; Man RY; Vanhoutte PM; Wang Y
    Circ Res; 2010 Apr; 106(8):1384-93. PubMed ID: 20203304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-Ionone represses renal cell carcinoma progression through activating LKB1/AMPK-triggered autophagy.
    Hou T; Wang Y; Dan W; Wei Y; Liu B; Que T; Lei Y; Yu B; Zeng J; Fan Y; Li L
    J Biochem Mol Toxicol; 2023 Jun; 37(6):e23331. PubMed ID: 36843289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation.
    Zhang YL; Guo H; Zhang CS; Lin SY; Yin Z; Peng Y; Luo H; Shi Y; Lian G; Zhang C; Li M; Ye Z; Ye J; Han J; Li P; Wu JW; Lin SC
    Cell Metab; 2013 Oct; 18(4):546-55. PubMed ID: 24093678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.
    Chen YS; Meng F; Li HL; Liu QH; Hou PF; Bai J; Zheng JN
    Oncotarget; 2016 Dec; 7(51):84299-84313. PubMed ID: 27732931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
    J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma.
    Wang Y; Dong D; Jiang S; Zhang E; Zheng W; Mao L; Li W; Zhou J; Fan L; Cheng R; Li Z; Fang Z; Gui Y; Li X
    Cell Physiol Biochem; 2018; 49(5):1755-1765. PubMed ID: 30231239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LKB1 promotes radioresistance in esophageal cancer cells exposed to radiation, by suppression of apoptosis and activation of autophagy via the AMPK pathway.
    He Q; Li J; Dong F; Cai C; Zou X
    Mol Med Rep; 2017 Aug; 16(2):2205-2210. PubMed ID: 28656285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of COUP-TFII inhibits cell proliferation and induces apoptosis through upregulating BRCA1 in renal cell carcinoma cells.
    Zheng J; Qin W; Jiao D; Ren J; Wei M; Shi S; Xi W; Wang H; Yang AG; Huan Y; Wen W
    Int J Cancer; 2016 Oct; 139(7):1574-85. PubMed ID: 27193872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration.
    Zheng X; Chi J; Zhi J; Zhang H; Yue D; Zhao J; Li D; Li Y; Gao M; Guo J
    Oncogene; 2018 Jan; 37(4):502-511. PubMed ID: 28967900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth.
    Qu YY; Zhao R; Zhang HL; Zhou Q; Xu FJ; Zhang X; Xu WH; Shao N; Zhou SX; Dai B; Zhu Y; Shi GH; Shen YJ; Zhu YP; Han CT; Chang K; Lin Y; Zang WD; Xu W; Ye DW; Zhao SM; Zhao JY
    Cancer Res; 2020 Jan; 80(2):319-333. PubMed ID: 31690668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.